1. CardioSpectra

    0 Comments Leave a Comment

    1-15 of 38 1 2 3 »
    1. Mentioned In 38 Articles

    2. Optical Coherence Tomography Used $500M of Federally Funded Research Over The Past Decade: How was it Used, What was Accomplished, and What’s to Come?

      Optical Coherence Tomography Used $500M of Federally Funded Research Over The Past Decade: How was it Used, What was Accomplished, and What’s to Come?
      ...udes Volcano Corporation acquiring intravascular OCT technology from startup Cardiospectra for $63M in 2007,  Cardiospectra was founded out of government sponsored OCT research at the University of Texas at Austin.  In E...
      Read Full Article
    3. Volcano Corporation Makes Big Bets on Optical Coherence Tomography: Projects OCT Cardiology & Related Markets At More Than $1B

      Volcano Corporation Makes Big Bets on Optical Coherence Tomography: Projects OCT Cardiology & Related Markets At More Than $1B
      ...rence Tomography (OCT) cardiology market and is backing that belief with big bets. Last year Volcano acquired CardioSpectra (a 2 year old startup company out of the University of Texas at Austin) for $63M ($25M plus an a...
      Read Full Article
    4. 1-15 of 38 1 2 3 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About CardioSpectra

    CardioSpectra

    CardioSpectra.  Cardiology Systems.  CardioSpectra was founded in 2005 by Marc D. Feldman, M.D., of the Health Science Center and Thomas E. Milner, Ph.D., of UT Austin. It was aquired by Volcano in 2007. CardioSpectra is looking for innovative ways to image blood vessel plaques that are vulnerable to rupture. A better method of imaging these plaques could dramatically reduce the number of sudden deaths from strokes and heart attacks precipitated by plaque ruptures. Dr. Feldman, an interventional cardiologist and researcher, is collaborating with Dr. Milner, a biomedical engineer.  Founded in 2005 and headquartered in San Antonio, Texas, CardioSpectra is focused on the development of innovative medical devices based upon an extensive patent portfolio of Optical Coherence Tomography (OCT) systems and associated technologies. OCT images are created by detecting light reflected from tissue, forming optical interference patterns that generate high- resolution 2D and 3D renderings of the tissue structure.

  3. Quotes about CardioSpectra

    1. We are also excited about the potential of our CardioSpectra acquisition and its Optical Coherence Tomography (OCT) technology as a complement to our IVUS offerings. Our product development program for this technology is on track and we hope to have our first offering in this area available for launch in the United States and Europe next year.
      Scott Huennekens in Volcano Reports 35 Percent Increase in Quarterly Revenues; Ivus ...